加多复合物与tris-hydroxypyridinone作为新成像探针的输入:热力学稳定性,分子建模和生物分布
Inês Dias1, Lurdes Gano2, Sílvia Chaves1
1Centro de Química Estrutural, Institute of Molecular Sciences, Departamento de Engenharia Química, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais 1, 1049-001 Lisboa, Portugal.
Molecules (Basel, Switzerland)
|March 27, 2025
概括
研究人员开发了一种新的加多 (Gd) 复合物,使用氧氨 (HOPO) 连接物用于磁共振成像 (MRI) 对比剂. 稳定复合体对未来的核磁共振成像诊断剂开发有希望.
科学领域:
- 金属协调医学化学 医学化学
- 新型对比剂的开发 新型对比剂的开发
- 磁共振成像 (MRI) 应用程序
背景情况:
- 基于加多的对比剂 (CA) 对MRI至关重要.
- 开发具有高稳定性和有效性的新型CA具有挑战性.
- 氧氨 (HOPO) 配体对Gd (III) 具有很高的亲和力.
研究的目的:
- 评估一种新的Gd(III) 复合物,其中含有三种3,4-HOPO 化部分的六三脚 (H3L).
- 评估这一新型Gd(III) 复合物的物理化学和生物特性.
- 探索其作为未来MRI诊断剂的潜力.
主要方法:
- 电位计被用来确定热力学稳定常量.
- 用分子模拟来分析复合物的结构和协调.
- 使用67Ga替代体复合物进行了体内生物分布研究.
主要成果:
- 形成了一个高度稳定的 (1:1) Gd-L 复合物 (log βGdL = 26.59),在酸性到中性pH中稳定.
- 分子模拟表明扭曲的八面体几何与全金属六面协调.
- 在体内研究表明代孕复合物的稳定性和快速分泌.
结论:
- 新型Gd(III) -HOPO复合体具有高热力学稳定性和有利的结构特征.
- 在体内研究表明稳定性好,清除速度快,这对CA发育至关重要.
- 这些发现为未来MRI诊断剂的设计提供了宝贵的见解.
更多相关视频
07:26Synthesis of 68Ga Core-doped Iron Oxide Nanoparticles for Dual Positron Emission Tomography /T1Magnetic Resonance Imaging
Published on: November 20, 2018
6.4K
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
14.9K
相关概念视频
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
63
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
63
01:24Magnetic Resonance Imaging
4.9K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
4.9K